Find trials
Search tips

A Study to Characterize the Genetic Profile of Karyomegalic Interstitial Nephritis (KIN) to Find Better Ways of Diagnosis and Treatment

Overview

About this study

The purpose of this study is to describe the clinicopathological features and characterize the genetic variants (by Whole exome sequencing).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patient with KIN post-kidney transplant and
  • Living-related kidney donor

Exclusion Criteria: 

  • None

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Sanjeev Sethi, M.D., Ph.D.

Closed for enrollment

Jacksonville, Fla.

Mayo Clinic principal investigator

Sanjeev Sethi, M.D., Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20424759

Mayo Clinic Footer